Patents by Inventor Xiujun Zhang
Xiujun Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240113135Abstract: Disclosed are a light-emitting module and a display device. The light-emitting module includes a substrate, a first driving circuit layer and at least one first light-emitting unit group. At least one first groove is provided on a surface of the substrate. The first driving circuit layer is located on the substrate and includes at least one first signal line located in the first groove. The first light-emitting unit group is located on a side, where the first driving circuit layer is provided, of the substrate, and includes at least one first lamp bead, and the first lamp bead is connected in series on the first signal line. In the light-emitting module, the first signal line is arranged in the first groove of the substrate, which is equivalent to being embedded in the substrate.Type: ApplicationFiled: December 1, 2023Publication date: April 4, 2024Applicant: SHINE OPTOELECTRONICS (KUNSHAN) CO., LTD.Inventors: Sheng ZHANG, Lixiang LIU, Shicheng ZHANG, Yi HUANG, Xiujun WANG
-
Patent number: 11911455Abstract: The nucleic acid sequences provided by the present invention comprises sequence HPV16-AVLS1 and sequence HPV16-AVLC1 in a 1:1 ratio; and sequence HPV18-AVLS1 and sequence HPV18-AVLC1 in a 1:1 ratio; the sequence AVLS1 and the sequence AVLC1 comprise two concatenated E6 proteins, two LI short peptides, two L2 short peptides, two concatenated E7 proteins, one PADRE sequence, and one adjuvant sequence respectively; the N-terminal of sequence AVLS1 carries a mouse IgK secretion peptide sequence; the N-terminal of sequence AVLC1 carries a ubiquitin sequence. The nucleic acid sequences provided by the present invention can not only induce high titer antibodies against E6/E7, but also elicit a high level of functional cellular immune, demonstrating excellent preventive and therapeutic effects against tumors related to HPV.Type: GrantFiled: August 25, 2023Date of Patent: February 27, 2024Assignee: Beijing Aeonvital Biomedicine Research Co., Ltd.Inventors: Xiujun Zhang, Lei Liu, Jianming Tang
-
Publication number: 20240051959Abstract: Disclosed herein are compounds that can prevent and treat C. difficile by inhibiting sporulation. Also disclosed herein are compositions and formulations comprising the compound disclosed herein. Methods of preventing and treating C. difficile comprising administering the compounds described herein are also disclosed.Type: ApplicationFiled: October 4, 2023Publication date: February 15, 2024Inventors: Yu CHEN, Michael SACCO, James LEAHY, Elena BRAY, Xingmin SUN, Xiujun ZHANG
-
Publication number: 20240009294Abstract: The nucleic acid sequences provided by the present invention comprises sequence HPV16-AVLS1 and sequence HPV16-AVLC1 in a 1:1 ratio; and sequence HPV18-AVLS1 and sequence HPV18-AVLC1 in a 1:1 ratio; the sequence AVLS1 and the sequence AVLC1 comprise two concatenated E6 proteins, two LI short peptides, two L2 short peptides, two concatenated E7 proteins, one PADRE sequence, and one adjuvant sequence respectively; the N-terminal of sequence AVLS1 carries a mouse IgK secretion peptide sequence; the N-terminal of sequence AVLC1 carries a ubiquitin sequence. The nucleic acid sequences provided by the present invention can not only induce high titer antibodies against E6/E7, but also elicit a high level of functional cellular immune, demonstrating excellent preventive and therapeutic effects against tumors related to HPV.Type: ApplicationFiled: August 25, 2023Publication date: January 11, 2024Inventors: Xiujun Zhang, Lei Liu, Jianming Tang
-
Patent number: 11814385Abstract: Disclosed herein are compounds that can prevent and treat C. difficile by inhibiting sporulation. Also disclosed herein are compositions and formulations comprising the compound disclosed herein. Methods of preventing and treating C. difficile comprising administering the compounds described herein are also disclosed.Type: GrantFiled: June 27, 2022Date of Patent: November 14, 2023Assignee: University of South FloridaInventors: Yu Chen, Michael Sacco, James Leahy, Elena Bray, Xingmin Sun, Xiujun Zhang
-
Publication number: 20230002381Abstract: Disclosed herein are compounds that can prevent and treat C. difficile by inhibiting sporulation. Also disclosed herein are compositions and formulations comprising the compound disclosed herein. Methods of preventing and treating C. difficile comprising administering the compounds described herein are also disclosed.Type: ApplicationFiled: June 27, 2022Publication date: January 5, 2023Inventors: Yu CHEN, Michael SACCO, James LEAHY, Elena BRAY, Xingmin SUN, Xiujun ZHANG
-
Patent number: 10688080Abstract: The present disclosure provides compositions including a beta-lactamase inhibitor, pharmaceutical compositions including a beta-lactamase inhibitor, methods of treatment of a condition (e.g., infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.Type: GrantFiled: July 30, 2018Date of Patent: June 23, 2020Assignees: UNIVERSITY OF SOUTH FLORIDA, The Regents of the University of CaliforniaInventors: Yu Chen, Nicholas Joseph Torelli, Orville Antonio Pemberton, Xiujun Zhang, Adam Renslo, Kyle Defrees, Priyadarshini Jaishankar
-
Patent number: 10465212Abstract: There is provided a recombinant bacterium comprising at least one overexpressed acyl-ACP thioesterase gene, and wherein at least one gene from the tricarboxylic acid cycle or glycolysis or both is inactivated. There is also provided a method for producing fatty acids, said method comprising culturing bacteria comprising at least one overexpressed acyl-ACP thioesterase gene in a growth medium in a container having walls; allowing said bacteria to secrete fatty acids; and collecting said fatty acids. Acid supplementation is also shown to increase productivity.Type: GrantFiled: March 18, 2016Date of Patent: November 5, 2019Assignee: William Marsh Rice UniversityInventors: Ka-Yiu San, Mai Li, Xiujun Zhang
-
Publication number: 20190254800Abstract: Provided is an implanted urinary control device, which comprises two tool handles. The tool handles each comprise a connecting portion, a urinary tract actuator and a handle actuator. The two tool handles are movably connected to each other via the connecting portions. The two handle actuators move relative to each other, thereby controlling an opening motion of a first urinary tract actuator relative to a second urinary tract actuator. The urinary tract actuator of one of the tool handles is positioned in front of the urinary tract actuator of the other one of the tool handles. The device further comprises tool handle rotation angle limiting mechanisms for limiting opening angles of the urinary tract actuators. The implanted urinary control device has a simple structure, induces less trauma, and provides an ideal urinary control effect.Type: ApplicationFiled: May 5, 2019Publication date: August 22, 2019Inventor: Xiujun ZHANG
-
Publication number: 20180333390Abstract: The present disclosure provides compositions including a beta-lactamase inhibitor, pharmaceutical compositions including a beta-lactamase inhibitor, methods of treatment of a condition (e.g., infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.Type: ApplicationFiled: July 30, 2018Publication date: November 22, 2018Inventors: Yu Chen, Nicholas Joseph Torelli, Orville Antonio Pemberton, Xiujun Zhang, Adam Renslo, Kyle Defrees, Priyadarshini Jaishankar
-
Publication number: 20160265010Abstract: There is provided a recombinant bacterium comprising at least one overexpressed acyl-ACP thioesterase gene, and wherein at least one gene from the tricarboxylic acid cycle or glycolysis or both is inactivated. There is also provided a method for producing fatty acids, said method comprising culturing bacteria comprising at least one overexpressed acyl-ACP thioesterase gene in a growth medium in a container having walls; allowing said bacteria to secrete fatty acids; and collecting said fatty acids. Acid supplementation is also shown to increase productivity.Type: ApplicationFiled: March 18, 2016Publication date: September 15, 2016Inventors: Ka-Yiu SUN, Mai LI, Xiujun ZHANG
-
Patent number: 9309543Abstract: There is provided a recombinant bacterium comprising at least one overexpressed acyl-ACP thioesterase gene, and wherein at least one gene from the tricarboxylic acid cycle or glycolysis or both is inactivated. There is also provided a method for producing fatty acids, said method comprising culturing bacteria comprising at least one overexpressed acyl-ACP thioesterase gene in a growth medium in a container having walls; allowing said bacteria to secrete fatty acids; and collecting said fatty acids. Acid supplementation is also shown to increase productivity.Type: GrantFiled: March 18, 2011Date of Patent: April 12, 2016Assignee: William Marsh Rice UniversityInventors: Ka-Yiu San, Mai Li, Xiujun Zhang
-
Publication number: 20140093921Abstract: There is provided a recombinant bacterium comprising at least one overexpressed acyl-ACP thioesterase gene, and wherein at least one gene from the tricarboxylic acid cycle or glycolysis or both is inactivated. There is also provided a method for producing fatty acids, said method comprising culturing bacteria comprising at least one overexpressed acyl-ACP thioesterase gene in a growth medium in a container having walls; allowing said bacteria to secrete fatty acids; and collecting said fatty acids. Acid supplementation is also shown to increase productivity.Type: ApplicationFiled: March 18, 2011Publication date: April 3, 2014Applicant: WILLIAM MARSH RICE UNIVERSITYInventors: Ka-Yiu San, Mai Li, Xiujun Zhang
-
Patent number: D837084Type: GrantFiled: December 21, 2017Date of Patent: January 1, 2019Assignee: SHENZHEN POWERUNION TECHNOLOGY CO., LTD.Inventor: Xiujun Zhang
-
Patent number: D920150Type: GrantFiled: December 18, 2020Date of Patent: May 25, 2021Assignee: SHANGHAI SHENGTOU ELECTRONIC TECHNOLOGY CO, LTD.Inventor: Xiujun Zhang
-
Patent number: D932337Type: GrantFiled: January 8, 2021Date of Patent: October 5, 2021Assignee: SUSONG BANGDE CLOTHING CO., LTD.Inventor: Xiujun Zhang